Cardiovascular Diseases backed by Aging to accelerate the Electrophysiology Ablation Market

Date : Nov 09, 2021 Author : PMR Editorial Staff Category : Healthcare

Atrial Fibrillation is known to affect more than 886K people every single year. Medical Journal of Australia has stated that Australia alone would be housing more than 600K cases of AF by the year 2034. These figures are enough to trigger the importance of electrophysiology ablation devices across the globe in the upcoming period. At the same time, the higher installation cost is bound to restrain the adoption of electrophysiology ablation devices, thereby slowing down the pace of this market in certain developing economies of MEA and LATAM. Persistence Market Research walks through the nitty-gritties of this market through its latest market study mentioned below.

How is the Electrophysiology Ablation Market scattered?

The global electrophysiological ablation market, by product, spans EP ablation catheters (cryoablation EP catheters, radiofrequency ablation catheters (irrigated-tip radiofrequency ablation catheters and conventional radiofrequency ablation catheters), microwave ablation systems, laser ablation systems, and navigational advanced mapping accessories), EP laboratory devices (EP X-Ray Systems, 3D mapping systems, EP recording systems, EP remote steering systems, and likewise), EP diagnostic catheters (conventional EP diagnostic catheters (fixed diagnostic catheters and steerable diagnostic catheters), advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters), access devices, and likewise.

Application-wise, the electrophysiology ablation market comprises AF (Atrial Fibrillation), Atrial Flutter, WPW (Wolff-Parkinson-White Syndrome), AVRNT (Atrioventricular Nodal Reentry Tachycardia), and likewise. Persistence Market Research has sketched these segregations along with probable call (s) to action in its latest market study entitled “Electrophysiology Ablation Market”.

The Way the Region-wise Analysis goes –

North America and Europe are already at the matured stage with respect to electrophysiology ablation. The Asia-Pacific is expected to create ripples in the electrophysiology ablation market in the forecast period. India and China are supposed to hold the baton. This could be reasoned with sedentary lifestyles, habitual drinking and smoking, and growing stress. Also, with ageing happening at a substantial rate, the demand for electrophysiology ablation is bound to escalate in the forecast period. Persistence Market Research has highlighted all these facts with insights in its latest market study entitled “Electrophysiology Ablation Market”.

The Competitive Zeal

Persistence Market Research, in its latest market study stated above, has profiled the key participants in electrophysiology ablation market as Abbott, Boston Scientific, Biosense Webster, Medtronic Plc, CathRx Ltd., Biotronik SE & Co. KG, Japan Lifeline Co., ATRICURE, Inc., Auris Health, and likewise. It has further mentioned developments like Stereotaxis going ahead with clearance from the US FDA for Genesis RMN System. Another one is that of Abbott inking a partnership with Switzerland-based CARE, wherein it did announce a 3-year program for screening, diagnosing, preventing, and managing NCDs (noncommunicable diseases) like cardiovascular diseases, diabetes, and several other chronic ones) for the people affected by armed conflict in Philippines (Marawi).

The other courses of developments listed by Persistence Market Research include Medtronic signing an agreement with EPIX Therapeutics for expanding the former’s portfolio of cardiac ablation with the latter’s proprietary temperature-controlled, catheter-based cardiac ablation system to treat patients suffering from cardiac arrhythmias. Antiarrhythmic drug market is bound to flourish along these lines. Apart from these facts and figures, Persistence Market Research has mentioned about Boston Scientific Corporation acquiring Securus Medical Group, Inc. for improvising on its electrophysiology cardiac ablation portfolio.

What’s in store for the next decade?

With cardiovascular ailments showing no signs of recession, the global electrophysiology ablation market is likely to go great guns in the next 10 years – Persistence Market Research